La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LJPC
The company's stock closed at $14.25 in Friday's trading on Nasdaq. The discovery does not ensure that Agouron will …
La Jolla Pharmaceutical Company (OTCQB: LJPC) ("La Jolla"), a leader in the development of therapeutics targeting galectin proteins, announced today that the FDA Office of Orphan Products Development has granted an "Orphan Drug" …
La Jolla Pharmaceutical Company (LJPC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LJPC given that, …